← FDA Drug Approvals (Drugs@FDA)
ONFI
NDA · New Drug Application · Sponsor: LUNDBECK PHARMS LLC · Approved 2012-12-14
Drug application
- FDA Application #
NDA203993
- Application type
- New Drug Application
- Brand name
- ONFI
- Generic name
- CLOBAZAM
- Active ingredients
- CLOBAZAM
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- LUNDBECK PHARMS LLC
- Manufacturer
- Lundbeck Pharmaceuticals LLC
- First approval
- 2012-12-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown